These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12109492)
21. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis. Skeik N; Gits CC; Ehrenwald E; Cragg AH Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656 [TBL] [Abstract][Full Text] [Related]
22. Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis. Mazighi M; Meseguer E; Labreuche J; Amarenco P Stroke; 2012 May; 43(5):1302-8. PubMed ID: 22529310 [TBL] [Abstract][Full Text] [Related]
23. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. IMS Study Investigators Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018 [TBL] [Abstract][Full Text] [Related]
24. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease]. Nagao K; Kanmatsuse K Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044 [No Abstract] [Full Text] [Related]
25. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [TBL] [Abstract][Full Text] [Related]
26. [Guidelines for intravenous thrombolytic therapy in acute ischemic stroke with special reference to those by the Ad Hoc Committee of the Japan Stroke Society]. Minematsu K No To Shinkei; 2006 Nov; 58(11):915-21. PubMed ID: 17133996 [No Abstract] [Full Text] [Related]
27. Is acute stroke treatment heading towards a more endovascular approach? Menon BK; Demchuk AM Lancet Neurol; 2009 Sep; 8(9):778-9. PubMed ID: 19647487 [No Abstract] [Full Text] [Related]
28. Thrombolysis at 3-4.5 hours after acute ischemic stroke onset--evidence from the Canadian Alteplase for Stroke Effectiveness Study (CASES) registry. Shobha N; Buchan AM; Hill MD; Cerebrovasc Dis; 2011; 31(3):223-8. PubMed ID: 21178345 [TBL] [Abstract][Full Text] [Related]
29. Randomised trials of endovascular treatment of stroke are needed. Ciccone A; Sterzi R Lancet Neurol; 2010 Jan; 9(1):30; author reply 31-2. PubMed ID: 20083033 [No Abstract] [Full Text] [Related]
30. Bolus-to-Infusion Time in Stroke Patients Treated with Alteplase on the CT Table: A Clinical Concern. Iglesias Mohedano AM; García Pastor A; de Lorenzo Pinto A; Gil Núñez AC Cerebrovasc Dis; 2019; 48(1-2):96-98. PubMed ID: 31593952 [No Abstract] [Full Text] [Related]
31. Adding to the effectiveness of intravenous tissue plasminogen activator for treating acute stroke. Grotta JC Circulation; 2003 Jun; 107(22):2769-70. PubMed ID: 12796412 [No Abstract] [Full Text] [Related]